Expertise in Fatty Acid Metabolism
Specialization in precisely controlling and diverting the fatty acid synthesis and degradation pathways to synthesize specific chain-length monomers (C6 to C12).
Polyester Diols are essential building blocks for high-performance polymers, coatings, and resins. Traditionally derived from petrochemical sources, there is increasing industrial demand for renewable, bio-based diols, especially medium-chain diols (C6 to C12), to improve the flexibility and sustainability of polyester and polyurethane materials.
CD Biosynsis focuses on developing robust microbial cell factories for the sustainable production of these medium-chain diols. We employ advanced metabolic engineering to design and optimize novel pathways in hosts like E. coli or yeast, leveraging fatty acid intermediates via the omega-oxidation and reduction pathways. Our strategy includes knocking out the beta-oxidation pathway to prevent product degradation, ensuring high titer and yield of long-chain diols for competitive, bio-based polymer manufacturing.
Get a QuoteThe biosynthesis of medium-chain polyester diols faces several critical limitations in microbial systems:
Overcoming these challenges requires comprehensive metabolic reprogramming to precisely control the carbon chain length and maximize product accumulation.
CD Biosynsis applies advanced synthetic biology and metabolic engineering to enhance the sustainable production of medium-chain diols:
Targeted Fatty Acid Pathway Engineering
We engineer the native fatty acid synthesis pathway (FAS) to control chain length and ensure efficient channeling of specific length intermediates (C6-C12) into the omega-oxidation route.
Beta-Oxidation Knockout for Yield
We perform gene knockout of the beta-oxidation pathway to prevent the degradation of fatty acid intermediates and the final diol product, ensuring maximum carbon yield and product accumulation.
Optimized omega-Oxidation and Reduction
We engineer and optimize the Cytochrome P450 systems for omega-oxidation and the terminal reductase enzymes to efficiently convert fatty acids into their corresponding diols, while managing cofactor supply.
Product Transport and Tolerance Engineering
We enhance the microbial host’s tolerance to the synthesized diol and intermediate aldehydes, often coupled with engineered efflux pumps to facilitate product excretion and improve final titer.
This comprehensive engineering approach enables the cost-effective and large-scale synthesis of high-purity, medium-chain bio-diols.
Choosing CD Biosynsis's Polyester Diol strain engineering service offers the following core value:
Expertise in Fatty Acid Metabolism
Specialization in precisely controlling and diverting the fatty acid synthesis and degradation pathways to synthesize specific chain-length monomers (C6 to C12).
Maximized Product Yield
The beta-oxidation knockout strategy ensures that the carbon flux is quantitatively captured in the form of the target diol, significantly increasing overall yield.
Sustainable Feedstock Utilization
The process is designed to utilize renewable, low-cost lipid-based feedstocks (fatty acids, oils), reducing reliance on petrochemical precursors.
High Monomer Purity
Targeted metabolic control and pathway balancing minimize side products, ensuring the high purity required for industrial polymerization processes.
Accelerated Commercial Viability
Engineered strains are optimized for robust performance and high titer, directly translating to reduced production and recovery costs at scale.
We are dedicated to providing genetically superior microbial strains to drive the commercial success of the bio-based polyester and resin markets.
CD Biosynsis's Polyester Diol strain engineering service follows a standardized research workflow, ensuring every step is precise and controllable:
Technical communication is maintained throughout the process, focusing on timely performance feedback and strategic adjustments to the metabolic engineering plan.
Accelerate your Bio-based Diol R&D and scale-up! CD Biosynsis provides customized strain engineering solutions:
What are the typical chain lengths of diols engineered?
We primarily focus on medium-chain diols ranging from C6 (1,6-Hexanediol) to C12 (1,12-Dodecanediol), which are highly sought after for improving the performance and flexibility of bio-based polyesters and resins.
Why is control over the fatty acid synthesis pathway important?
Precise control is needed to ensure the cell produces the fatty acid intermediate of the exact required chain length (e.g., C10) before it enters the omega-oxidation pathway. This prevents the formation of mixed-chain diols and ensures high product purity.
Can this process use cheap sugar as a feedstock?
Yes. By engineering hosts like E. coli or yeast, we enable the cell to efficiently convert low-cost sugar (glucose, glycerol) into the necessary fatty acid intermediates, providing a versatile and sustainable feedstock option.
How do you ensure the high purity required for polymerization?
Purity is ensured through targeted metabolic engineering (minimizing byproducts) and the use of robust downstream analytical methods (GC/HPLC) to verify the final monomer quality, preventing catalyst poisoning or side reactions during polymerization.
What is the estimated project timeline?
Due to the complexity of engineering long, non-native pathways and achieving specific chain-length control, a complete project, including pathway editing, knockout, and fermentation validation, typically requires 18-24 weeks.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.